GB9717766D0 - Methods - Google Patents

Methods

Info

Publication number
GB9717766D0
GB9717766D0 GBGB9717766.1A GB9717766A GB9717766D0 GB 9717766 D0 GB9717766 D0 GB 9717766D0 GB 9717766 A GB9717766 A GB 9717766A GB 9717766 D0 GB9717766 D0 GB 9717766D0
Authority
GB
United Kingdom
Prior art keywords
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9717766.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9717766.1A priority Critical patent/GB9717766D0/en
Publication of GB9717766D0 publication Critical patent/GB9717766D0/en
Priority to JP2000507836A priority patent/JP2001514013A/ja
Priority to AU88147/98A priority patent/AU8814798A/en
Priority to GB0001527A priority patent/GB2342717B/en
Priority to EP98939738A priority patent/EP1007738A1/en
Priority to US09/485,636 priority patent/US6316196B1/en
Priority to PCT/GB1998/002468 priority patent/WO1999010529A1/en
Priority to US09/984,842 priority patent/US20030077592A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9717766.1A 1997-08-22 1997-08-22 Methods Pending GB9717766D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9717766.1A GB9717766D0 (en) 1997-08-22 1997-08-22 Methods
JP2000507836A JP2001514013A (ja) 1997-08-22 1998-08-18 Ltc4シンターゼ多型の分析方法および診断への利用
AU88147/98A AU8814798A (en) 1997-08-22 1998-08-18 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use
GB0001527A GB2342717B (en) 1997-08-22 1998-08-18 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use
EP98939738A EP1007738A1 (en) 1997-08-22 1998-08-18 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use
US09/485,636 US6316196B1 (en) 1997-08-22 1998-08-18 Methods for analyzing LTC4 synthase polymorphisms and diagnostic use
PCT/GB1998/002468 WO1999010529A1 (en) 1997-08-22 1998-08-18 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use
US09/984,842 US20030077592A1 (en) 1997-08-22 2001-10-31 Methods for analyzing LTC4 synthase polymorphisms and diagnostic use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9717766.1A GB9717766D0 (en) 1997-08-22 1997-08-22 Methods

Publications (1)

Publication Number Publication Date
GB9717766D0 true GB9717766D0 (en) 1997-10-29

Family

ID=10817852

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9717766.1A Pending GB9717766D0 (en) 1997-08-22 1997-08-22 Methods
GB0001527A Expired - Fee Related GB2342717B (en) 1997-08-22 1998-08-18 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0001527A Expired - Fee Related GB2342717B (en) 1997-08-22 1998-08-18 Methods for analyzing ltc4 synthase polymorphisms and diagnostic use

Country Status (6)

Country Link
US (2) US6316196B1 (enExample)
EP (1) EP1007738A1 (enExample)
JP (1) JP2001514013A (enExample)
AU (1) AU8814798A (enExample)
GB (2) GB9717766D0 (enExample)
WO (1) WO1999010529A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881571B1 (en) 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2798392B1 (fr) * 1999-09-13 2005-07-15 Exonhit Therapeutics Sa Marqueurs genetiques de la toxicite, preparation et utilisations
AU3793701A (en) * 1999-11-29 2001-06-04 Orchid Biosciences, Inc. Methods of identifying optimal drug combinations and compositions thereof
WO2001079560A2 (en) * 2000-04-17 2001-10-25 Glaxo Group Limited Medicine response assay in respiratory disease
CN1329012A (zh) * 2000-06-21 2002-01-02 上海博德基因开发有限公司 一种新的多肽——烟酰胺腺嘌呤脱氧二核苷酸依赖性白三烯b412-羟基脱氢酶36和编码这种多肽的多核甘酸
US20050009023A1 (en) * 2001-07-03 2005-01-13 Neil Richtand Glucocorticoid-induced receptor and methods of use
CA2458303A1 (en) * 2001-09-17 2003-03-27 Janssen Pharmaceutica N.V. Brain expressed cap-2 gene and protein associated with bipolar disorder
US7833706B2 (en) * 2003-01-30 2010-11-16 Celera Corporation Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
US20050019795A1 (en) * 2003-04-24 2005-01-27 Aventis Pharma Deutschland Gmbh Analysis and use of PAR1 polymorphisms for evaluating the risk of cardiovascular disorders
EP2186913B1 (en) * 2003-11-26 2016-02-10 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US20090297563A1 (en) * 2004-10-27 2009-12-03 Anders Borglum Diagnosis And Treatment of Immune-Related Diseases
WO2007059348A2 (en) * 2005-11-17 2007-05-24 Third Wave Technologies, Inc. Compositions and methods for detecting an hcv-1 subtype
EP2027284A2 (en) * 2006-05-18 2009-02-25 Sanofi-Aventis Use of adamts4 gene and protein polymorphisms
CA2653794C (en) * 2006-06-30 2012-05-01 Clifford L. Librach Method of detecting preeclampsia
WO2008033239A2 (en) * 2006-09-11 2008-03-20 Applera Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
WO2008039941A2 (en) 2006-09-27 2008-04-03 The Government Of The Usa As Represented By The Secretary Of The Dpt. Of Health And Human Services Scgb3a2 as a growth factor and anti-apoptotic agent
US7811765B2 (en) * 2006-10-12 2010-10-12 Children's Hospital & Research Center At Oakland Methods and compositions for determining predisposition to inflammation-mediated cardiovascular disease
US20080248470A1 (en) * 2007-04-04 2008-10-09 Sungkyunkwan University Foundation For Corporate Collaboration Genetic screening for predicting antidepressant drug response based on the monoamine transporter gene polymorphism combination
US9079961B2 (en) * 2007-05-25 2015-07-14 Japanese Red Cross Society GPIIIa gene
WO2009052160A1 (en) * 2007-10-19 2009-04-23 Marshfield Clinic Method for administering anticoagulation therapy
WO2009061734A1 (en) * 2007-11-05 2009-05-14 The Government Of The United States Of America As Represented By The Secretary Of The Deparment Of Health And Human Services Identification of subjects likely to benefit from statin therapy
US7947451B2 (en) * 2007-11-30 2011-05-24 Celera Corporation Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
US10023913B2 (en) * 2008-01-29 2018-07-17 The Johns Hopkins University SR-BI as a predictor of elevated high density lipoprotein and cardiovascular disease
US20110112186A1 (en) * 2008-02-29 2011-05-12 Isis Innovation Limited Diagnostic methods
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
DE102008064509B4 (de) * 2008-12-22 2017-06-08 Robert Bosch Gesellschaft mbH für medizinische Forschung Verfahren zur Bestimmung der Prädisposition für Morbus Crohn
CA2706021C (en) * 2009-05-28 2018-10-16 Institut De Cardiologie De Montreal Genetic predictors of international normalized ratio (inr) fluctuation with warfarin therapy
WO2011068610A1 (en) * 2009-12-01 2011-06-09 Quest Diagnostics Investments Incorporated Methods for detecting risk of myelodysplastic syndrome by genotypic analysis
US9732389B2 (en) 2010-09-03 2017-08-15 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
WO2012082912A2 (en) * 2010-12-14 2012-06-21 Tufts Medical Center, Inc. Markers related to age-related macular degeneration and uses therefor
US9534256B2 (en) * 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
AU2012322018B2 (en) 2011-10-13 2017-09-21 Boston Heart Diagnostics Compositions and methods for treating and preventing coronary heart disease
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
US10098893B2 (en) * 2013-10-03 2018-10-16 Northwestern University Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457
EP3149487B1 (en) * 2014-05-29 2020-02-12 Geneticure LLC Improved therapeutic regimen for hypertension
US11761043B2 (en) 2014-05-29 2023-09-19 Geneticure Inc. Machine assay and analysis for selecting antihypertensive drugs
US10260108B2 (en) * 2014-11-04 2019-04-16 University of Pittsburgh—of the Commonwealth System of Higher Education PARP genomic variants conferring resistance and sensitization to chemotherapy under inhibition
CA2968221A1 (en) 2014-11-17 2016-05-26 Boston Heart Diagnostic Corporation Cardiovascular disease risk assessment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018178A1 (en) * 1992-03-13 1993-09-16 The Children's Hospital Of Philadelphia DIAGNOSIS OF β-THALASSEMIA USING A MULTIPLEX AMPLIFICATION REFRACTORY MUTATION SYSTEM
CA2136239C (en) 1992-06-15 2004-10-05 Donald W. Nicholson Leukotriene c4 synthase
WO1995032280A1 (en) * 1994-05-20 1995-11-30 Brigham And Women's Hospital Dna encoding human leukotriene c4 synthase, polypeptides, and uses therefor
US5952210A (en) * 1994-06-03 1999-09-14 G. D. Searle & Company Nucleic acids and expression vectors encoding human leukotiene C4 synthase
AU2927797A (en) 1996-05-06 1997-11-26 Brigham And Women's Hospital 5-lipoxygenase gene polymorphisms and their use in classifying patients

Also Published As

Publication number Publication date
US20030077592A1 (en) 2003-04-24
EP1007738A1 (en) 2000-06-14
GB2342717A (en) 2000-04-19
AU8814798A (en) 1999-03-16
WO1999010529A1 (en) 1999-03-04
JP2001514013A (ja) 2001-09-11
US6316196B1 (en) 2001-11-13
GB0001527D0 (en) 2000-03-15
GB2342717B (en) 2001-11-28

Similar Documents

Publication Publication Date Title
GB9717766D0 (en) Methods
DE59806556D1 (en) Fmcw-sensor
DE59803915D1 (en) Bandwaage
DE59805100D1 (en) Containerbrücke
DE59803341D1 (en) Handhobelmaschine
DE59808840D1 (en) Compoundpumpe
GB9708918D0 (en) Methods
DE69727985D1 (en) Extravasationserkennungsvorrichtung
DE59803148D1 (en) Dimensionsstabile thermoplastische formmassen
DE59811907D1 (en) Transponder-system
GB9707742D0 (en) Methods
GB9718591D0 (en) Methods
DE59708342D1 (en) Basophilen-degranulationstest
DE69729893D1 (en) Druckbläter
DE69715258D1 (en) Präzisionshydraulikfutter
DE59806884D1 (en) Dexamethason-gel
ZA985543B (en) Novel methods
DE69735266D1 (en) Substituierte naphthopyrane
DE59811113D1 (en) Laryngoskop
GB9724384D0 (en) Methods
CA79884S (en) Moniitor
CA82218S (en) Sports-glasses
CA80851S (en) Thermomter
CA82745S (en) Handleset
CA82746S (en) Handleset